2001Immunological JournalRequires access

Lamivudine can restore HBV-specific cytotoxic activities in patients with CHB

Zhang Hu

Open publisher page 0 citations

Abstract

ObjectiveTo study whether anti viral treatment by lamivudine can reconstitute CTL responses in CHB patients Methods PBMCs were separated routinely during lamivudine or interferon α treatment,and stimulated by peptide HBcAg18 27/rHBcAg/rIL 2.The cytotoxic activities against HBV DNA transfected hepatoma cells(2 2 15) and HepG2 cells were detected by lactate dehydrogenase(LDH) assay after 21 days cultivation Results The cytotoxic activities against HepG2 2 15 cells increased significantly by whether lamivudine or interferon α treatment which have not obviously effect on the cytotoxic activities against HepG2 cells The increased HBV specific CTL activities by interferon α treatment lasted longer than lamivudine treatment Conclusion Treatment with lamivudine could restore HBV specific CTL activities partly and transiently but could not eliminate HBV persistently

About this research paper

What this paper is about

ObjectiveTo study whether anti viral treatment by lamivudine can reconstitute CTL responses in CHB patients Methods PBMCs were separated routinely during lamivudine or interferon α treatment,and stimulated by peptide HBcAg18 27/rHBcAg/rIL 2.The cytotoxic activities against HBV DNA transfected hepatoma cells(2 2 15) and HepG2 cells were detected by lactate dehydrogenase(LDH) assay after 21 days cultivation Results The cytotoxic activities against HepG2 2 15 cells increased significantly by whether lamivudine or interferon α treatment which have not obviously effect on the cytotoxic activities against HepG2 cells The increased HBV specific CTL activities by interferon α treatment lasted longer than lamivudine treatment Conclusion Treatment with lamivudine could restore HBV specific CTL activities partly and transiently but could not eliminate HBV persistently

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

ObjectiveTo study whether anti viral treatment by lamivudine can reconstitute CTL responses in CHB patients Methods PBMCs were separated routinely during lamivudine or interferon α treatment,and stimulated by peptide HBcAg18 27/rHBcAg/rIL 2.The cytotoxic activities against HBV DNA transfected hepatoma cells(2 2 15) and HepG2 cells were detected by lactate dehydrogenase(LDH) assay after 21 days cultivation Results The cytotoxic activities against HepG2 2 15 cells increased significantly by whether lamivudine or interferon α treatment which have not obviously effect on the cytotoxic activities against HepG2 cells The increased HBV specific CTL activities by interferon α treatment lasted longer than lamivudine treatment Conclusion Treatment with lamivudine could restore HBV specific CTL activities partly and transiently but could not eliminate HBV persistently

Key concepts: Lamivudine, Cytotoxic T cell, CTL*, Interferon, Virology, Peripheral blood mononuclear cell, Medicine, Immunology

Related papers

Back to paper searchBrowse research topicsOriginal source
Lamivudine can restore HBV-specific cytotoxic activities in patients with CHB — Research Paper | ScholarLens